Non-Replicative Transduction Particles for Accurate Bacterial Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing viral-based reporter systems face limitations due to lytic cycles of viruses, superinfection immunity, host restriction mechanisms, and difficulties in separating transduction particles from native virus particles, leading to inaccurate and inefficient detection of target nucleic acids in cells.

Innovation Solution

Development of non-replicative transduction particles using a bacterial cell packaging system that prevents packaging of bacteriophage nucleic acid molecules by modifying packaging initiation sites, allowing for the expression of reporter molecules without viral replication, and utilizing a plasmid with a second bacteriophage gene to facilitate packaging of reporter nucleic acid molecules.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If replication-competent transduction particles are used to deliver reporter molecules, then reporter expression is achieved, but lytic cycle activity causes deleterious effects and reduces assay accuracy

Engineering Contradiction:
Improveassay accuracyVSAvoidlytic cycle activity
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The bacteriophage genome is segmented into two separate components: (1) a replication-competent bacteriophage genome that provides packaging functions, and (2) a reporter nucleic acid molecule that contains the reporter gene and packaging initiation site. This segmentation allows the replication functions to be separated from the reporter expression functions, enabling the production of non-replicative transduction particles that deliver reporters without causing lytic cycle activity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The packaging initiation site sequence is extracted from the bacteriophage genome and placed into the reporter nucleic acid molecule. This extraction allows the reporter molecule to be specifically packaged by the bacteriophage packaging machinery while the bacteriophage genome itself cannot be packaged due to the deletion of its packaging initiation site, thereby producing only non-replicative transduction particles.

Inventive Principle:
Principle #2Taking out (Extraction)

2Productivity

If transduction particles are produced using wild-type bacteriophage, then packaging efficiency is high, but separation of non-replicative transduction particles from replication-competent viruses becomes difficult

Engineering Contradiction:
Improvepackaging efficiencyVSAvoidparticle purity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The packaging initiation site sequence is removed from the bacteriophage genome and transferred to the reporter nucleic acid molecule. This creates an asymmetric system where only the reporter molecule can be packaged, not the bacteriophage genome itself, ensuring that all produced particles are non-replicative transduction particles without requiring separation procedures.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of attempting to prevent packaging of the bacteriophage genome and then separating it from transduction particles, the approach is inverted: the bacteriophage genome is engineered to be incapable of packaging, while only the reporter nucleic acid molecule is designed to be packaged. This inversion eliminates the need for separation and ensures particle purity by design.

Inventive Principle:
Principle #13The other way round (Inversion)

3Reliability

If lysogenic cycle is used for reporter assays, then reporter expression occurs, but superinfection immunity and host restriction systems limit host range and detection sensitivity

Engineering Contradiction:
Improvedetection sensitivityVSAvoidhost range
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The packaging initiation site is extracted from the bacteriophage genome and placed in the reporter molecule, enabling specific packaging of reporter molecules into transduction particles. This approach allows delivery of reporters into a broader range of host cells without being constrained by lysogenic cycle limitations such as superinfection immunity and host restriction systems.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system transitions from a static lysogenic cycle with fixed host range limitations to a dynamic transduction particle-based system that can deliver reporters into diverse host cells. The non-replicative transduction particles can infect cells that would otherwise be resistant to lysogenic phage infection, expanding the effective host range and detection sensitivity.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentEP3699592B1Non-replicative transduction particles and transduction particle-based reporter systems
Publication Date: 2026.04.29 GENEWEAVE BIOSCIENCES INC
  • EP3699592B1 patent drawingFigure 1
  • EP3699592B1 patent drawingFigure 2
  • EP3699592B1 patent drawingFigure 3

AI summary

Methods and systems are provided for packaging reporter nucleic acid molecules into non-replicative transduction particles for use as reporter molecules. The non-replicative transduction particles can be constructed from viruses and use viral transduction and replication systems. The reporter nucleic acid molecules include a reporter gene, such as a reporter molecule or selectable marker, for detecting target genes or cells. Methods and systems are provided for detection of cells and target nucleic acid molecules using the non-replicative transduction particles as reporter molecules.